Search research articles
Contact Us
Filters
Showing results (191-200 of 206) with videos related to
Page
of 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2014
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity
Phuc Felix Nguyen-Tan, Qiang Zhang, K Kian Ang, et al.
Nature Communications
|
December 6, 2014
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13
Peijing Zhang, Li Wang, Cristian Rodriguez-Aguayo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2016
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129
Canhua Xiao, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2006
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer
, David G Pfister, Scott A Laurie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2009
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer
Benjamin J Moeller, Vishal Rana, Blake A Cannon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 23, 2010
Prospective imaging assessment of mortality risk after head-and-neck radiotherapy
Benjamin J Moeller, Vishal Rana, Blake A Cannon, et al.
Molecular Cancer Therapeutics
|
June 10, 2010
Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer
Lauren Averett Byers, F Christopher Holsinger, Merrill S Kies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2014
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522
K Kian Ang, Qiang Zhang, David I Rosenthal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2014
Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes
Michaela K Keck, Zhixiang Zuo, Arun Khattri, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2005
Head and neck cancers
Arlene A Forastiere, Kian Ang, David Brizel, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 206) with videos related to
Sort By:
Page
of 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2014
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity
Phuc Felix Nguyen-Tan, Qiang Zhang, K Kian Ang, et al.
Nature Communications
|
December 6, 2014
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13
Peijing Zhang, Li Wang, Cristian Rodriguez-Aguayo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2016
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129
Canhua Xiao, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2006
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer
, David G Pfister, Scott A Laurie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2009
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer
Benjamin J Moeller, Vishal Rana, Blake A Cannon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 23, 2010
Prospective imaging assessment of mortality risk after head-and-neck radiotherapy
Benjamin J Moeller, Vishal Rana, Blake A Cannon, et al.
Molecular Cancer Therapeutics
|
June 10, 2010
Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer
Lauren Averett Byers, F Christopher Holsinger, Merrill S Kies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2014
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522
K Kian Ang, Qiang Zhang, David I Rosenthal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2014
Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes
Michaela K Keck, Zhixiang Zuo, Arun Khattri, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 9, 2005
Head and neck cancers
Arlene A Forastiere, Kian Ang, David Brizel, et al.
Page
of 21